EUVIMEDEUVIMED entdecken
Crossref

An Integrated DNA Origami-Based RNA Degrader for Targeted Degradation of Oncogenic Mutant KRAS mRNA

Ying-Fu Li, Qing Huang, Pin-Ru Chen, Hua-Dong Li, Pei-Qiang Ma, Bang-Ce Ye, Bin-Cheng Yin

ACS Pharmacology & Translational Science · 13.11.2026 · 9 (11) · 3159-3168

DOI: 10.1021/acsptsci.6c00228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 02.10.2026. Verfasst von Ying-Fu Li und 6 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, the Natural Science Foundation of Shanghai.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting mutant KRAS represents a critical yet unmet therapeutic challenge across multiple malignancies, as the structural diversity of oncogenic variants and absence of druggable pockets have impeded the development of effective small-molecule inhibitors. Here, we report an integrated RNA degrader system constructed on a six-helix bundle DNA origami (6HB) scaffold that enables efficient and targeted degradation of mutant KRAS mRNA. The system coassembles two modular functional units: an enzyme activity control module comprising an engineered barnase variant and a programmable recognition strand for direct, endogenous-machinery-independent RNA cleavage, and a cell-penetrating module featuring TAT peptides for cytosolic delivery. This integrated architecture eliminates spatiotemporal barriers between delivery and catalysis, achieving robust KRAS mRNA degradation within 16 h while maintaining sufficient specificity for mutant transcripts with minimal impact on wild-type forms. This study demonstrates a proof-of-concept nanoscale platform that integrates targeting, delivery, and catalytic functions for RNA degradation.

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • the Natural Science Foundation of Shanghai

Zitieren

APA

Li, Y., Huang, Q., Chen, P., Li, H., Ma, P., Ye, B., & Yin, B. (2026). An Integrated DNA Origami-Based RNA Degrader for Targeted Degradation of Oncogenic Mutant KRAS mRNA. ACS Pharmacology & Translational Science, 9(11), 3159-3168. https://doi.org/10.1021/acsptsci.6c00228

Vancouver

Li Y, Huang Q, Chen P, Li H, Ma P, Ye B, et al. An Integrated DNA Origami-Based RNA Degrader for Targeted Degradation of Oncogenic Mutant KRAS mRNA. ACS Pharmacology & Translational Science. 2026;9(11):3159-3168. doi:10.1021/acsptsci.6c00228

BibTeX
@article{Li2026,
  author = {Li, Ying-Fu and Huang, Qing and Chen, Pin-Ru and Li, Hua-Dong and Ma, Pei-Qiang and Ye, Bang-Ce and Yin, Bin-Cheng},
  title = {An Integrated DNA Origami-Based RNA Degrader for Targeted Degradation of Oncogenic Mutant KRAS mRNA},
  journal = {ACS Pharmacology & Translational Science},
  year = {2026},
  volume = {9},
  number = {11},
  pages = {3159--3168},
  doi = {10.1021/acsptsci.6c00228}
}
Kostenlos starten →